La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « Keywords » - entrée « Experimental disease »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Experience < Experimental disease < Experimental protocol  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]
Ident.Authors (with country if any)Title
000599 (2007) Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada]Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia
000793 (2005) Bianca Marchetti [Italie] ; Pier Andrea Serra [Italie] ; Cataldo Tirolo [Italie] ; Francesca L'Episcopo [Italie] ; Salvo Caniglia [Italie] ; Florinda Gennuso [Italie] ; Nuccio Testa [Italie] ; Egidio Miele [Italie] ; Speranza Desole [Italie] ; Nicholas Barden [Canada] ; Maria Concetta Morale [Italie]Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism : pivotal role for glia-neuron interactions
000988 (2002) J. Q. Lu [Canada] ; A. J. Stoessl [Canada]Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats
000B94 (2000) C. S. Lee [Canada] ; M. A. Cenci [Suède] ; M. Schulzer [Canada] ; A. Björklund [Suède]Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
000C23 (1999) M. C. Evans [États-Unis] ; A. Pradhan [Canada] ; S. Venkatraman [États-Unis] ; W. H. Ojala [États-Unis] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis]Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring α, α-disubstituted amino acids
000C56 (1999) T. Inoue [Canada, Japon] ; J. Tsui [Canada] ; N. Wong [Canada] ; SHIN YI WONG [Canada] ; F. Suzuki [Japon] ; YIN NAM KWOK [Canada]Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment
000C64 (1999) E. M. Khalil [États-Unis] ; W. H. Ojala [États-Unis] ; A. Pradhan [Canada] ; V. D. Nair [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis]Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide
000C69 (1999) F. Calon [Canada] ; M. Morissette [Canada] ; M. Goulet [Canada] ; R. Grondin [Canada] ; P. J. Blanchet [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys : effects on basal ganglia GABAA/ benzodiazepine receptor complex and GABA content
000D78 (1997) N. A. Tatton [Canada] ; S. J. Kish [Canada]In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and Acridine Orange Staining
000D93 (1997) P. W. Baures [États-Unis] ; W. H. Ojala [États-Unis] ; W. J. Costain [Canada] ; M. C. Ott [Canada] ; A. Pradhan [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis]Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide
000E26 (1996) E. I. Miklyaeva [Canada] ; I. Q. Whishaw [Canada]HemiParkinson analogue rats display active support in good limbs versus passive support in bad limbs on a skilled reaching task of variable height
000E28 (1996) M. Goulet [Canada] ; R. Grondin ; P. J. Blanchet ; P. J. Bedard ; T. Di Paolo [Canada]Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode to not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys
000E29 (1996) P. J. Blanchet [Canada] ; R. Grondin ; P. J. BedardDyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates
000E36 (1996) R. Grondin [Canada] ; M. Goulet [Canada] ; T. Di Paolo [Canada] ; P. J. Bedard [Canada]Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates
000F10 (1994) P. J. Blanchet [Canada] ; R. Boucher [Canada] ; P. J. BedardExcitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys
000F36 (1993) M. Takada [Canada] ; T. Sugimoto ; T. Hattori [Canada]MPTP neurotoxicity to cerebellar Purkinje cells in mice
000F44 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. BedardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
000F46 (1993) B. D. Pate [Canada] ; T. Kawamata ; T. Yamada ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada]Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices
000F50 (1993) C. Gagnon [Canada] ; B. Gomez-Mancilla ; P. J. Bedard ; T. Di Paolo [Canada]Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors
000F79 (1992) A. Tabatabaei [Canada] ; T. L. Perry ; S. Hansen ; C. KriegerPartial protective effect of MK-4801 on MPTP-induced reduction of striatal dopamine in mice
000F89 (1992) B. Gomez-Mancilla [Canada] ; J.-F. Latulippe ; R. Boucher ; P. J. BedardEffect of ethosuximide on rest tremor in the MPTP monkey model

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "Experimental disease" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "Experimental disease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Experimental disease
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022